Nuveen LLC Invests $6.93 Million in LifeStance Health Group, Inc. $LFST

Key Points

• Nuveen LLC has invested approximately $6.93 million in LifeStance Health Group by acquiring over 1 million shares, representing about 0.27% ownership of the company.
• Insider trading activity has seen significant stock sales, with insiders collectively selling over 20 million shares in the last three months, which is a 12.36% and 20.05% decrease in their holdings, respectively.
• LifeStance Health Group reported a 10.6% year-over-year increase in revenue for the last quarter, reaching $345.31 million, and the company holds a consensus rating of "Moderate Buy" with a target price of $8.50.

Nuveen LLC purchased a new position in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 1,040,309 shares of the company's stock, valued at approximately $6,928,000. Nuveen LLC owned about 0.27% of LifeStance Health Group as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in shares of LifeStance Health Group by 5.0% in the first quarter. Vanguard Group Inc. now owns 11,221,237 shares of the company's stock worth $74,733,000 after acquiring an additional 531,841 shares during the last quarter. Jennison Associates LLC raised its holdings in shares of LifeStance Health Group by 2.1% in the first quarter. Jennison Associates LLC now owns 8,255,236 shares of the company's stock worth $54,980,000 after acquiring an additional 168,856 shares during the last quarter. Wellington Management Group LLP raised its holdings in shares of LifeStance Health Group by 9.2% in the fourth quarter. Wellington Management Group LLP now owns 5,276,237 shares of the company's stock worth $38,886,000 after acquiring an additional 445,796 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of LifeStance Health Group by 87.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company's stock worth $25,977,000 after acquiring an additional 1,643,390 shares during the last quarter. Finally, Parcion Private Wealth LLC acquired a new position in shares of LifeStance Health Group in the first quarter worth $15,670,000. 85.50% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at LifeStance Health Group

In other LifeStance Health Group news, insider Ujjwal Ramtekkar sold 16,000 shares of the business's stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $5.94, for a total transaction of $95,040.00. Following the completion of the sale, the insider owned 113,435 shares of the company's stock, valued at approximately $673,803.90. The trade was a 12.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder Silversmith Partners I. Gp, Llc sold 3,592,357 shares of the business's stock in a transaction dated Monday, August 18th. The shares were sold at an average price of $5.07, for a total value of $18,213,249.99. Following the sale, the insider directly owned 14,324,197 shares of the company's stock, valued at approximately $72,623,678.79. This trade represents a 20.05% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 20,423,643 shares of company stock worth $103,561,790 in the last three months. 6.60% of the stock is currently owned by insiders.

LifeStance Health Group Price Performance

Shares of NASDAQ:LFST opened at $5.55 on Monday. The company has a market cap of $2.16 billion, a P/E ratio of -111.00 and a beta of 1.13. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.19. LifeStance Health Group, Inc. has a 52 week low of $3.74 and a 52 week high of $8.61. The business has a fifty day simple moving average of $4.67 and a 200-day simple moving average of $5.98.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported ($0.01) EPS for the quarter, beating analysts' consensus estimates of ($0.03) by $0.02. LifeStance Health Group had a negative return on equity of 1.11% and a negative net margin of 1.23%.The business had revenue of $345.31 million during the quarter, compared to the consensus estimate of $345.05 million. During the same quarter in the previous year, the business earned ($0.06) earnings per share. The business's revenue for the quarter was up 10.6% on a year-over-year basis. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Equities research analysts forecast that LifeStance Health Group, Inc. will post -0.18 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on LFST shares. BTIG Research began coverage on LifeStance Health Group in a report on Friday, July 25th. They issued a "buy" rating and a $8.00 price target for the company. Wall Street Zen raised LifeStance Health Group from a "hold" rating to a "buy" rating in a research report on Saturday, August 9th. Finally, UBS Group lifted their price objective on LifeStance Health Group from $8.50 to $9.00 and gave the company a "buy" rating in a research report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $8.50.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Want to see what other hedge funds are holding LFST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.